1. Baik, N. G., Ahn, B. O., Lee, S. B., Kim, W. B., Yang, J., and Watanabe, T., A study on cardiotoxicity of DA-125, a new anticancer antibiotic.J. Appl. Pharmacol., 1, 9–19 (1993).
2. Chung, M. G., Lee, S. B., Han, S. S., and Roh, J. K., Reproductive toxicity of DA-125, a new anthracycline anticancer agent: peri- and postnatal study in rats.J. Appl. Pharmacol., 3, 38–46 (1995).
3. DePamphilis, M. L., Chalifour, L. E., Cherette, M. F., Cusick, M. E., Hay, R. T., Henderson, E. A., Pritchard, C. G., Tack, L. C., Wassarman, R. M., Weaver, D. T., and Wirak, D. O., Papovavirus chromosomes as a model for mammalian DNA replication. In: Cozzarelli, N. R. (Ed). Mechanisms of DNA replication and recombination. Alan R Liss, New York, pp. 423–427 (1983).
4. Donehower, R. C., Meyers, C. E., and Chabner, B. A., New developments on the mechanisms of action of antineoplastic drugs.Life Sci., 25, 1–14 (1979).
5. Douc-Rasy, S., Kayser, A., and Riou, G. F., Inhibition of the reactions catalyzed by a type topoisomerase and a catenating enzyme ofTrypanosoma cruzi by DNA-intercalating drugs.EMBO J., 3, 11–21 (1984).